The CMS has a proposed a rule that would expedite the Medicare
coverage approval process for medical devices that receive a breakthrough
designation from the FDA. Under the Medicare Coverage of Innovative Technology
proposal, Medicare would allow four years of national coverage for
FDA-designated breakthrough devices, starting on the day market authorization
is awarded, and the new rules would extend to devices approved in 2019 and
2020.
No comments:
Post a Comment